Home » Topics » Regulatory » Patents

Patents
RSS

New carbapenems in development at Takeda

Jan. 8, 1998

COX-2 inhibitors under study at Abbott

Jan. 8, 1998

Protein farnesyltransferase inhibitors disclosed by Schering-Plough

Jan. 8, 1998

Bristol-Myers Squibb prepares melatonergic agents

Jan. 7, 1998

SKB reports prodrugs of 5-HT2C receptor antagonists

Jan. 7, 1998

More on peptidomimetic protein farnesyltransferase inhibitors from Merck & Co.

Jan. 7, 1998

Warner-Lambert develops new ET antagonists

Jan. 7, 1998

Fujisawa isolates new agent for influenza

Jan. 7, 1998

Taiho describes compounds for post-PTCA restenosis

Jan. 7, 1998

Tanabe Seiyaku patents new ACAT and lipid peroxidation inhibitors

Jan. 7, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...